News & Analysis on Clinical Trial Services & Contract Research And Development
Sygnature Discovery has launched an in vivo inflammation model, that the company says is ‘exciting but only the beginning’ of understanding life-limiting neuroinflammatory conditions.
AstraZeneca’s small molecule drug, Tagrisso (Osimertinib) achieved unprecedented survival in early-stage epidermal growth factor receptor mutated (EFGRm) lung cancer.
Paid for and content provided by DHL Supply Chain
Logistics is so much more than the movement of goods, it can enhance patient retention, improve patient diversity, reduce costs get products to market faster.